AC Immune (ACIU) Operating Margin Growth (1y) (2016 - 2026)

AC Immune (ACIU) Operating Margin Growth (1y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1,552.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1,536.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -170.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1,049.00
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 AC Immune 230.22 Mn 230.22 Mn - 63,503.00

Historic Data

Download Data
DateValue
Mar 31, 2026 63,503.00
Dec 31, 2025 -262,111.00
Sep 30, 2025 -175,014.00
Jun 30, 2025 156,656.00
Dec 31, 2020 12,675.00
Sep 30, 2020 -249,167.00
Jun 30, 2020 -47,071.00
Mar 31, 2020 -13,962.00
Dec 31, 2019 -89,630.00
Sep 30, 2019 134,516.00
Jun 30, 2019 -40,725.00
Mar 31, 2019 85,671.00
Mar 31, 2018 -30,379.00
Mar 31, 2017 71,493.00
Dec 31, 2016 89,891.00
Sep 30, 2016 -70,053.00